There are many different types and sponsors of clinical trials/research.
The National Cancer Institute sponsors some; academic institutions, pharmaceutical
companies, major hospitals, private physicians and cooperative groups
sponsor others. They all play an important role in diversifying the range
of oncology clinical research, as well as increasing access to trials
at a community level.
Cancer Trials Support Unit (CTSU) is an example of one of a number of major
cooperative groups that conduct research projects for the National Cancer
Institute. Many institutions are involved in researching unique treatments
for the prevention and/or cure of cancer as well as measuring the impact
of new treatments on the quality of life of the cancer patient. Cooperative
groups are nationally based organizations, but usually have local partnerships
with major research institutions in metropolitan areas.
Cooperative groups may address a number of different types of cancer, or
they may focus on new treatment and/or therapy design protocols. Access
to cooperative group clinical research allows patients to be proactive
and informed about their cancer treatment options.
Insurance companies often cover the costs of the chemotherapy and/or radiation,
as these treatments are often already FDA approved and considered the
standard of care for cancer treatment (however, some exceptions may apply).
In the case of investigational agents, or brand new treatments that have
not been approved by the FDA, the group sponsoring the study normally
provides them at no cost to the patient.
Clinical trials strive to answer important scientific questions and suggest
future research directions. Because of progress made through clinical
trials, many people treated for cancer are now living longer.
Our physicians are able to offer patients the most current treatment available
through their participation in various types of clinical research studies.
New trials are constantly opening and closing enrollment. For more information
regarding oncology clinical trials that may appeal to you, please ask
your physicians or contact the Clinical Trials Coordinator at
909.865.9555 extension 2875.
.png)
